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Abstract: Extensive employment of biomaterials in the areas of biomedical and microbiological
applications is considered to be of prime importance. As expected, oil based polymer materials
were gradually replaced by natural or synthetic biopolymers due to their well-known intrinsic
characteristics such as biodegradability, non-toxicity and biocompatibility. Literature on this subject
was found to be expanding, especially in the areas of biomedical and microbiological applications.
Introduction of porosity into a biomaterial broadens the scope of applications. In addition, increased
porosity can have a beneficial effect for the applications which exploit their exceptional ability
of loading, retaining and releasing of fluids. Different applications require a unique set of pore
characteristics in the biopolymer matrix. Various pore morphologies have different characteristics
and contribute different performances to the biopolymer matrix. Fabrication methods for bio-based
porous materials more related to the choice of material. By choosing the appropriate combination
of fabrication technique and biomaterial employment, one can obtain tunable pore characteristic to
fulfill the requirements of desired application. In our previous review, we described the literature
related to biopolymers and fabrication techniques of porous materials. This paper we will focus on
the biomedical and microbiological applications of bio-based porous materials.
Keywords: biomaterial; biocompatibility; porosity
1. Introduction
In the competitive world, synthetic polymers in which the desired properties can be easily
modified according to the needs are generally used as substitutes for biopolymers. Degree of branching,
molecular weight, chemical substituents, and main chain sites can be more readily changed and
organized in synthetic polymers than in most biomaterials [1,2]. Some biomaterials show property
variations resulting from different environmental and agronomic factors, such as weather and other
complicated considerations. These limitations render biopolymers relatively unattractive at the
commercial level [3].
At present, the socio-economic situation has changed to widen the applications of biopolymers.
Issues on oil supply, oil price hike, and sustainability have directed scientists to focus on alternative
and sustainable resources [4]. In addition, natural materials are environmental friendly because of
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their biodegradability, non-toxicity, and low disposal costs [5]. Moreover, the use of natural materials
such as starch for fillers in composite materials is cheaper compared with the use of synthetic polymer
matrices [6]. These biopolymers consist of polysaccharides, such as starch, cellulose, chitin/chitosan,
alginate, and polysaccharides (wool, gelatin, silk, and collagen) synthesized from bacterial, fungal,
and animal proteins [7,8].
As defined by Williams [9], the biocompatibility is a characteristic of a system and not a material.
Furthermore, biomaterial is a substance that has been engineered to interact with biological systems in
controlled manner [9,10]. Therefore, it is described that biomaterial as biocompatible system when
discussed about its biocompatibility characteristics.
Given their uses as biocompatible systems, these biomaterials are superior over conventional
polymer materials in various applications [11]. As biocompatible systems, these biomaterials may
interact with different biological systems in different ways such as tissue processes involved in wound
healing, the endothelium in contact with intravascular devices, the target cells in gene therapy and the
stem cells in bioreactors. In many products of medical technology, more than one biomaterials may
involve and the interactions between these materials may play some role in biocompatibility [9].
Biomaterials are widely used in many applications because of their high specific surface area,
high specific strength, and low relative density [12–15]. Modern technologies provide powerful tools
to fabricate the porous structures of biomaterials and to enhance the natural biosynthetic systems
for targeted applications. Porous architectures have been fabricated using different techniques, such
as solvent casting, particulate leaching, gas foaming, phase separation, electrospinning, porogen
leaching, fiber mesh, rapid prototyping, and freeze drying, to meet the requirements of different
applications [16].
Porous biopolymer matrices are used for biomedical applications such as tissue engineering,
control drug delivery systems and wound healing [17]. It is also a popular candidate for microbiological
applications such as encapsulation of microorganism in fermentative industry, in the production of
probiotic food, biosorption and bioremediation of chemicals and as antimicrobial food packaging
material [18]. In tissue engineering, scaffolds provide a framework for cell attachment, migration,
differentiation, and induction of new tissue shape formation [19]. Aside from biodegradability,
biocompatibility and mechanical properties, porosity is also an important consideration when
selecting a desirable scaffold for tissue engineering [20]. Considering the stable and uniform porous
structure, tunable pore sizes, increased surface area and surface properties of porous materials, many
studies have exerted considerable efforts to develop porous biopolymers as controlled drug delivery
matrices [21]. The porosity of the biopolymer matrix is important for wound healing applications
because it allows cell filtration and provides high permeability for the diffusion of oxygen and
nutrients [22]. Several biopolymers are available for microbial encapsulation in porous matrices to
hold the microorganisms for water purification, biomolecule production, and ethanol production.
Encapsulation of microorganisms in porous matrix provide several advantages such as resistance to
environmental stressor and enhance the viability of microorganisms, promote controlled release and
optimize delivery of microorganisms (probiotic) to the site of action [23]. Bio-based porous materials
have been used to incorporate antimicrobial agents to food packaging materials for preservation of
food. It provides an effective way to control spoilage microorganisms and food-borne pathogens thus
enhance food safety and decrease product spoilage [23].
This paper presents a review regarding the biomedical and microbiological applications of
bio-based porous materials and the details of intricate features of the microarchitecture of porous
matrices, such as porosity and pore morphology, fabricated using various methods.
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2. Biomedical Applications
2.1. Porous Scaffold for Tissue Engineering
Disease, injury, or trauma can damage tissues, and treatments are needed to facilitate the repair,
replacement, or regeneration of damaged tissues in the human body. Typical treatments include tissue
transplantation from one site of the body to another or from one individual to another. Major problems
associated with these techniques are painful operation, high cost, risk of refusal by the patient’s
immune system, and risk of introducing infection or disease from the donor to the patient. Tissue
engineering aims to regenerate damaged tissues without replacing them by combining body cells on a
highly porous scaffold biomaterial, which acts as a template for tissue regeneration. These templates
should not only provide biodegradability, biocompatibility, and other mechanical features but also
high porosity and interconnected pore structure to facilitate the satisfactory diffusion of nutrients to
cells within the template and to the extracellular medium formed by these cells [24]. Biodegradability
is often an essential feature of a biomaterial used in tissue engineering since it acts as a temporary
template for tissue forming in place until the natural extracellular matrix has sufficiently developed.
Beyond that point, the scaffold should degrade into nontoxic end products which are capable of being
disposed of by the body leaving only the newly formed tissue.
A wide variety of cell seeding techniques have been explored to improve cell seeding efficiency
and uniform distribution [25–30]. The simplest of which involves placing the desired amount of cell
suspension on the top of the scaffold and letting the liquid slowly drip into the porous structure of
the scaffold. After initial seeding, the scaffold is removed from culture plate and placed in the site of
implantation of the body. As the cells grow, migrate, and multiply, the scaffolding degrades naturally
in the body leaving newly formed tissue. Figure 1 represents the process of tissue formation in the
cell-implanted bioscaffold.
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Figure 1. Schematic representation of tissue regeneration using porous bioscaffold.
The surface area-to-volume ratio of these porous matrices depends on the density and average
diameter of the pores. Given that the diameter of cells dictates the minimum pore size depending on
the intended applications, the pore size of the scaffold must be carefully controlled. Table 1 shows
the optimal pore size for cell infiltration reported by previous researchers [25–30]. When the pores are
too small, seeding cells in the middle of the scaffold and feeding the inner parts of the scaffolds are
limited. Large pores improve the stability of the scaffold and help provide physical support for the
seeded cells [31].
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Table 1. Optimal pore size for cell infiltration reported by previous researchers [25–30].
Cell types cultured Optimal pore size (µm) Reference
Hepatocytes 20 µm [26]
Osteogenic cells 100–150 µm [27]
Fibroblast 5–15 µm [26]
Adult mammalian skin cells 20–125 µm [28]
Smooth muscle cells 60–150 µm [29]
Endothelial cells <80 µm [30]
Scaffolds with a desired porosity, pore size and interconnectivity are required by various tissue
engineering applications because the pore morphology strongly affects the cell growth. Ideal pore sizes
vary for different cells and tissues. Fabrication methods are closely related to pore size and structure.
Pore size, pore interconnectivity and porosity can be controlled by varying the process parameters of
fabrication method and material composition of scaffold matrix.
2.1.1. Porous Scaffold by Thermally Induced Phase Separation
Thermally induced phase separation is a well-known, simple and versatile fabrication method
for the preparation of porous scaffolds. In this technique, a polymer solution is prepared at high
temperature and phase separation is achieved by cooling down the homogenous solution. Subsequent
freeze-drying of the phase-separated polymer solution produces porous structures as a result of solvent
removal. Ma et al. [32] fabricated porous scaffolds from poly(L-lactic acid) through thermally induced
phase-separation for the cultivation of small-diameter blood vessels. It was observed that the porosity
reduced from 95% to 90% and the average pore size decreased from 120–150 µm to 80–120 µm when
the polymer concentration was increased from 2.5% to 10%. The pore size greatly decreased from
115–140 µm to 20–40 µm with the decrease in phase-separation temperature from −20 to −196 ◦C.
Pavia et al. [33] developed chitosan/poly(DL-lactide-co-glycolide) composites by thermally induced
phase separation for applications in tissue engineering. Composites were frozen at −78 ◦C for 3 or
6 h. The solvent was then extracted by a freeze drying. It was found that more uniform and larger
pores were formed inside the composite than in the surface. This was because of temperature gradient
of the cooling rate of the freezing process. In addition, faster cooling rates tend to produce smaller
crystals because there is not sufficient time for large particles to form. As a result, small pore sizes
were obtained at faster cooling rates, because the cooling rate was inversely related to the crystal size
obtained [34].
2.1.2. Porous Scaffold by Freeze-Drying/Lyophilization
Freeze-drying/lyophilization is another simple and versatile technique that can be applied for
fabrication of broad range of biomaterial scaffolds. It involves freezing the material and then reducing
the surrounding pressure to allow the frozen water in the material to sublimate. The porous structures
are created by the ice crystals that sublimate, leaving gaps or pores in their place. Li et al. [35] used
lyophilization to prepare porous chitosan scaffolds for cultivation of rat hepatocytes. Scaffolds with
a porosity of 90% and mean pore sizes ranging from 50 to 200 µm were obtained using this method.
The processing conditions were 4 ◦C for 6 h for gellation, frozen at −28 ◦C, and then lyophilized in
a freeze-dryer followed by rehydration step. Hydroxyapatite and gelatin composite scaffolds were
prepared using solvent casting combined with freeze drying. The molds were frozen at −70 ◦C
and then dried in a commercial freeze-dryer for 6 h for solvent removal. Results showed that the
prepared scaffold had an open, interconnected porous structure with a pore size of 80–400 µm [36].
Chitosan scaffolds were prepared by cross-linking with glutaraldehyde for cultivation of human
dermal fibroblasts. The porosity and pore size of the scaffolds were controlled by varying the freezing
rate to form ice crystals of varying sizes. With this technique, the pore size of the scaffold was
40–140 µm, and the average porosity was about 93% ± 12.57% [37].
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2.1.3. Porous Scaffold by Supercritical Fluid Processing
The use of supercritical CO2 for the fabrication of porous scaffold has attracted interests in recent
years due to the absence of using organic solvents. Pore structure and porosity of the scaffold can
be effectively controlled by varying the saturation pressure, temperature, and processing time of
this method. Porous scaffolds were prepared using composite biomaterials (poly(lactic-co-glycolic
acid)/hyaluronic acid/collagen) and fabricated with supercritical CO2 for osteoblast cell culture.
A porosity of 88.9% and a pore size of 205.7 µm were obtained when the scaffold was fabricated at
18 MPa pressure and 45 ◦C for 45 min [38]. Teng et al. [39] had reported that the porosities of poly (D,L)
lactic acid/hydroxyapatite scaffold decreased with increasing the CO2 saturation pressures. It was
observed that the porosity decreased from 92% ± 2% to 47% ± 2% when the pressure was increased
from 10 to 14 MPa. It was also found that the porosity of the scaffold increased when the saturation
time increased from 15 to 60 min. In addition, the porosity of the composites at 40 ◦C was slightly
higher than that of composites formed at 35 ◦C under the same saturation time.
Table 2 lists the summary of pore characteristics of biopolymer scaffolds prepared from different
fabrication methods for culturing different types of cells [32,35–38].
Table 2. Summary of pore characteristics of biopolymer scaffolds prepared from different fabrication
methods for culturing different types of cells [32,35–38].
Cell/tissue type Biopolymer Method of fabrication Pore characteristics Reference
Small-diameter
blood vessels
Poly(L-lactic acid)
(PLLA)
Thermally induced
phase-separation
Porosity decreased from 95%
to 90% with increasing the
polymer concentration from
2.5% to 10%. Pore size
decreased from 115–140 µm to
20–40 µm with decreasing the
phase-separation temperature
from −20 to −196 ◦C
[32]
Hepatocytes Chitosan Lyophilization Porosity of 90% and meanpore size between 50–200 µm [35]
Bone tissue Hydroxyapatiteand gelatin
Solvent-casting method
combined with freeze
drying
Open, interconnected porous
structure with a pore size of
80–400 µm and porosity 70%
[36]
Human dermal
fibroblasts Chitosan Freeze drying
Pore size between 40–140 µm,
and average porosity about
93% ± 12.57%
[37]
Osteoblast
Poly(lactic-co-glycolic
acid)/Hyaluronic
acid/collagen
Supercritical CO2
Porosity of 88.9% and pore
size of 205.7 µm [38]
2.2. Porous Carriers for Drug Delivery
In controlled drug delivery systems, an active therapeutic agent is integrated into a polymeric
matrix to release the drug from the material in a predetermined manner. Depending on the drug
delivery design and the application, the drug release time may be a few hours or a few months to
several years [40]. Figure 2 illustrates the drug diffusion from the biopolymer matrix containing
dispersed drug at a specific time.
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Hydrogels are cross-linked polymer matrices with several hydrophilic groups or domains.
Although these materials are hydrophilic, the presence of chemical or physical bonds between polymer
chains prevents the dissolution of hydrogel in water. Binding of polymer chains is achieved either by
noncovalent physical associations and physical entanglements or by covalent cross-linkages [41].
Drugs are incorporated into hydrogel in two ways. One is through post-loading, wherein a drug
is loaded after hydrogel networks are formed. If the hydrogel system is inert, diffusion is the major
driving force for drug uptake and release. In the presence of drug-binding ligands in the hydrogel,
drug-polymer interaction and drug diffusion must both be considered in any model description of
release. The other is through in situ loading, wherein drugs or drug-polymer conjugates are introduced
to polymer precursor solution. In this method, hydrogel formation and drug encapsulation occur
simultaneously. In such cases, drug release depends on hydrogel swelling, diffusion, reversible
drug-polymer interactions, or degradation of labile covalent bonds [42].
When the pore size of a hydrogel is greater than the molecular size of the drug, the diffusion
coefficient can be related to the porosity and tortuosity of the hydrogel. For hydrogels with pore sizes
closer to the drug molecular size or nonporous hydrogels, drug diffusion coefficients are decreased
because of the steric hindrance of polymer chains. In such cases, the average free volume for drug
molecules is decreased and the hydrodynamic drag toward the drug is increased, causing increased
drug diffusion path length compared with hydrogels with pore sizes much larger than that of the
encapsulated drug [42].
A wide range of biopolymers have been investigated as drug carriers. Porous biomaterials
as drug delivery carriers have been designed using natural polymers, such as chitosan, due
to their well-documented biodegradability, nontoxicity and biocompatibility. Phaechamud and
Charoenteeraboon [43] had developed chitosan sponge containing doxycycline hyclate using freeze
drying, and the drug release and sustainable antibacterial activity of this material were studied in
the presence of a high concentration of chitosan in the hydrogel. The pore density of the sponge
prepared with 10% (w/w) chitosan solution was higher than that of the sponge prepared with 4% and
7% (w/w) chitosan solutions; the shape and volume of the pores were consistent. In the presence of a
high concentration of chitosan, the pores were well interconnected and the pore diameter was about
80–130 µm. The high pore surface area allowed a large amount of the drug to be loaded into the matrix.
The pore volume of the chitosan sponge diminished after cross-linking with glutaraldehyde solution.
However, doxycycline hyclate could be effectively loaded to cross-linked chitosan sponge, and the
drug release from the cross-linked chitosan sponge was higher than that from the noncross-linked
chitosan sponge. Mirzaei B et al. [44] had investigated the properties of glutaraldehyde-cross-linked
chitosan hydrogel with varying cross-linking concentrations for drug delivery system of amoxicillin
trihydrate. The pore size increased from 100 to 500 µm with increasing cross-linking agent from 1:0.068
to 1:0.30. Hydrogel with 20 mol % cross-linker showed the best swelling behavior for drug release [44].
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Microporous and Superporous Matrices for Drug Delivery
Porous materials are highly attractive as controlled drug delivery matrices because of their
controllable pore size and porous structure. Microporous and superporous structures of polymer
matrices control the passage between the external and internal surfaces of a solid, allowing materials to
pass in or out of the solid [18]. Microporous-structured poly-lactic acid scaffolds were prepared
using a robotic dispensing technique and room-temperature ionic liquid for drug loading and
delivery studies of ampicillin and cytochrome C. Macroporous channels with controlled pore
configuration were obtained by a robotic dispensing technique. Room-temperature ionic liquid
created the bicontinuous interpenetrating network in the macroporous channels formed by robotic
dispensing. The average pore size was 2.43 µm, and the microporosity was ~70%. The microporous
scaffolds showed greater drug loading capacity (4–5 times increase in ampicillin and 9–10 times
increase in cytochrome C) compared with the nonmicroporous scaffolds. The release of ampicillin
from microporous scaffolds was initially faster and then slowed down, showing continual release
over a month. Cytochrome C exhibited a sustainable release over a month [45]. Microporous
hydroxyapatite/chitosan composite beads were prepared by ionic crosslinking to be used as a system of
sustained drug delivery to bone. Beads were formed to encapsulate tetracycline hydrochloride by ionic
crosslinking using tripolyphosphate and freeze drying. Open pore channels and an interconnected
framework were obtained, and most of these pores were of irregular shape. The average pore
diameter was about 45 ± 17 µm. The pore size decreased with increasing hydroxyapatite content.
In addition, small pores facilitated higher absorption of drug and sustained release compared with
large pores [46]. Carboxymethylcellulose-based microporous hydrogels were prepared by crosslinking
with 1,3-diaminepropane. Microporous structure with different pore sizes (14, 30 and 40 µm) was
obtained and drug release kinetics was analyzed for ibuprofen-lysin. It was reported that the drug
release rate extended from 24 h to 7 days with increasing the pore size of the microporous hydrogel
from 14 µm to 30–40 µm. This was mostly due to the more internal distribution of the drug in the
largest pore dimension hydrogels [47].
Superporous hydrogels consist of hydrophilic polymers and show high swelling ratios and
rapid swelling properties due to the presence of interconnected microscopic pores. Bioadhesive
superporous hydrogel composite particles were prepared from hydroxypropyl-methylcellulose and
chitosan biopolymers using gas blowing for intestinal drug delivery. Composite particles with a pore
size of 100–1000 µm and a porosity of 47.11% ± 1.80% were obtained for drug (metoprolol succinate)
delivery studies. The particles showed more than 80% drug loading and drug release up to 10 h [48].
Chitosan/poly(vinyl alcohol) interpenetrating polymer network type superporous hydrogel was
prepared using gas foaming method for the drug delivery of rosiglitazone maleate [49,50]. Superporous
hydrogels showed very fast swelling rate which resulted in high swelling ratio. It showed a rapid
release of drug and reached to equilibrium state around 100 min. In addition, release profile showed
similar pattern with the swelling properties of these superporous hydrogel [49]. The interconnected
pores and capillary channels are the typical features of superporous hydrogel network. Owing to its
porous structure, it exhibits faster swelling rate as well as larger equilibrium swelling ratio. Udeni
Gunathilake et al. [51] reported the development of superporous chitosan hydrogel reinforced with
nanocellulose for the enhancement of bioavailability of curcumin. Highly interconnected and large
pore structures were fabricated using carbon dioxide gas foaming method. It was observed that the
drug loading efficiency and amount of drug release increased in the hydrogel fabricated using gas
foam method when compared with the hydrogels formed at atmospheric condition. Table 3 lists the
summary of pore characteristics of different drug delivery matrices prepared from various fabrication
methods [43–46,48–51].
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Table 3. Pore characteristics of different drug delivery systems prepared from various fabrication
method [43–46,48–51].
Type of drug Biopolymer Method of fabrication Pore characteristics Reference
Doxycycline
hyclate Chitosan Freeze drying
Well interconnected pores with
diameter about 80–130 µm [43]
Ampicillin and
cytochrome C Poly(lactic acid)
Robotic dispensing
technique and room
temperature ionic liquid
Pore size of 2.43 µm and
microporosity of ~70% [45]
Metoprolol
succinate
Hydroxypropyl-
methylcellulose and
chitosan
Gas blowing Pore size between 100–1000 µmand porosity of 47.11% ± 1.80% [48]
Amoxicillin
trihydrate Chitosan Freeze drying
Pore sizes were obtained
from100 to 500 µm with
increasing the crosslinking agent
from 1:0.068 to 1:0.30 (molar
ratio-chitosan: crosslinker)
[44]
Tetracycline
hydrochloride Hydroxyapatite/chitosan Freeze drying Pore diameter 45 ± 17 µm. [46]
Rosiglitazone
maleate
Chitosan/poly(vinyl
alcohol) Gas foaming
Superporous hydrogel with
capillary porous structures.
Porosity increased from
38.3 ± 2.2 to 88.2 ± 2.1 with
increasing the amount of
glyoxal (crosslinker)
[49]
Ranitidine Carboxymethylcellulosehydrogel Gas foaming
Porosity decreased from
69.30 ± 4.36 to 42.38 ± 2.68 with
the addition of sodium
carboxymethyl cellulose
[50]
Curcumin
Nanocellulose
reinforced chitosan
hydrogel
Gas foaming Highly interconnected poreswith pore sizes >100 µm [51]
2.3. Wound Healing Material
Wound dressings are commonly used in wound healing. An ideal wound dressing material
should allow gaseous exchange, absorb exudates and toxic compounds, maintain high humidity at
the applied surface, provide thermal insulation, protect the wound from bacterial contamination, be
nontoxic, be removed easily, be easily handled without any damages, be sterilizable, and be free from
leaving foreign particles in the wound. Biodegradable wound dressings can be used to treat wounds
that are difficult to remove [52].
Depending on the required property, the hydrophilicity, swelling ratio and porosity, and
degradation of a wound dressing material are controlled using bioactive hydrogels to regulate the
rate of fluid passage from the wound, enhance the diffusion of encapsulated drug, and release the
by-products into the wound and help in tissue regeneration, respectively [53]. Water absorption
behavior is an important characteristic of wound dressing materials. The absorption of excessive
fluid in wound surface is critical to wound healing. Water uptake is related to the capillary capacity
of the material, which generally depends on the size and amount of pores. However, the suction
capacity does not depend completely on porosity. The open porosity (accessible by the liquid) and
pore tortuosity of the solid also affect the capillary capacity of the material [54].
Different bioactive hydrogels, such as those based on chitosan, collagen, hyaluronic acid,
alginate, or elastin biopolymers, can be used to control the properties of wound dressing materials.
Alginate-based dressings can be used to treat dry wounds after treatment with saline. They show high
swelling ratios and can absorb large exudate volumes in wounds. As the main structural protein in
connective tissues, collagen provides extracellular matrix structures for wound dressing materials [53].
Chitin and chitosan stimulate cell adhesion and proliferation, as well as help in the organization of
the extracellular matrix. The antibacterial and fungicidal properties of both polymers also render them
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attractive for wound healing applications. Hyaluronan is another main component of the extracellular
matrix used for chronic wound treatment, and elastin is a protein present in connective tissues that
demonstrates load-bearing and stretchable properties. Elastin participates in extracellular matrix
production, cell migration, and protease synthesis [53,55].
The antibacterial activity is also an important factor on selecting a wound dressing for wound
healing. Straccia et al. [56] developed alginate hydrogels coated with chitosan for wound dressing and
studied the antibacterial activity on Escherichia coli. Antibacterial activity was carried out using solid
agar medium contact method. Results showed that presence of microbial inhibition zone around the
contact area in the case of coated hydrogels and completely absent in uncoated hydrogels [52].
Mechanical properties are the most important character in hydrogel properties, which prevent
physical damage to the wound and to support easy handling and storage. The mechanical
and functional properties of collagen and fibrin hydrogels were characterized for wound healing
applications. The pore sizes of 2.84 and 1.69 µm and the void ratios of 80.15% and 71.46% were
obtained for collagen and fibrin hydrogels, respectively. In addition, fibrin hydrogel showed lower
permeability and greater shear modulus compared with collagen hydrogel [57]. Kim et al. [58] prepared
poly(vinyl alcohol)/alginate hydrogel containing nitrofurazone for wound dressing purposes. They
have used the freeze-thawing method to crosslink poly(vinyl alcohol)/sodium alginate blended
polymer. It was observed that the mechanical properties of poly(vinyl alcohol)/sodium alginate
hydrogel film increased with increasing the sodium alginate contents. El Salmawi [59] reported
the preparation of poly(vinyl alcohol)/chitosan wound dressing hydrogel using different doses of
γ-radiation to induce crosslinking. Results referred that the mechanical properties of the hydrogels
blend increased with increasing poly(vinyl alcohol) concentration.
3. Microbiological Applications
3.1. Encapsulation of Microorganisms in Food Industry
For successful immobilization of microorganisms, a matrix must exhibit high chemical and
biological stability, mechanical strength, large surface, porosity and appropriate permeability to
diffusion and transport of oxygen, essential nutrients, metabolic waste and secretory products.
Brewing and winemaking industry are mainly based on the microorganisms for their alcoholic
fermentation process. Instead of using free cells, fermentation process is facilitated by immobilizing
the yeast cells on several organic materials such as polysaccharides (calcium alginate, carrageenan,
pectin), poly(vinyl alcohol), modified polystyrene and modified polyethylene. It is reported that in
winemaking process, cell immobilization on biomaterials such as alginate, cellulose, carrageenan,
agar, pectine, chitosan and gelatine contributes inhibiting the toxic influence of produced ethanol on
microorganisms. Immobilization of microorganisms improve the condition of the process as well as on
the properties of the product such as quality of their flavor [60].
There are two methods of entrapment of yeast to the porous matrices. In the first method cells are
allowed to diffuse in to the porous matrix. The movement of grown cells is hindered by other cells and
the matrix. In the second method, porous matrix is formed in situ around the cells. Natural polymeric
materials such as Ca-alginate, α-carrageenan and agar are being used to form the hydrogel beads with
this method. These polymeric hydrogel beads have less attraction in fermentation industry due to
several drawbacks such as chemical and physical instability, limited diffusion of nutrients, oxygen and
metabolites and high cell population in gel beads [61,62].
Traditional beer fermentation technology with freely suspended yeast cells takes about 7 days
for the production of beer with a subsequent maturation stage of several weeks. Higher fermentation
temperature with selected specific yeast strain takes about 12–15 days to finish the production of
beer. Immobilized cell technology is able to produce beer within 1–2 days. The main difficulty is to
obtain the correct balance of sensory compounds to give the acceptable flavor profile within short
period of time [63]. Another problem related to this method is leakage of yeast cells from the matrix
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to the medium. Some studies demonstrated that this problem can be overcome by creating a barrier
membrane to the gel matrix. This can be achieved by the addition of an extra polymer [64].
Microorganisms produce aldehydes, ketones and acids by the partial degradation of sugar, alcohol
and aldehyde by using their enzymes. Gluconobacter oxydans is a very small size microorganism leading
to difficulties in the reuse or recycling of the cells for large-scale production processes. By immobilizing
bacteria to porous chitosan sponge, 92% activity recovery and 74% reusability were obtained [65]. Also,
no cell loss was observed in this process. Morphological studies showed that cells were attached to the
surface of the pores (100–400 µm) and the activity recovery increased with increasing the porosity [65].
Different matrices can be used to immobilize microorganisms to improve the productivity of
vinegar/acetic acid. Acetobacter aceti bacterial cells were immobilized in calcium alginate gel beads by
fluidized bed type column reactors. The study revealed that both of the concentration and productivity
of the acetic acid in this immobilized cell systems were two fold greater than those in the free cells
systems [66]. Fumi et al. [67] reported that the oxygen uptake rate decreased with increasing the
alginate concentration of calcium alginate beads used for immobilization of acetobacter in vinegar
production. This may be due to the fact that the porosity of the gel beads decreased with increasing
alginate concentration. Sun and Furusaki [68] found that the productivity of acetic acid increased at
the lower dilution rate for the system with larger gels. However, the productivity decreased with
the increase of the dilution rate for larger gels. This decrease was due to the significant decrease in
the suspended cell population, which caused the cell catalyzed reaction rate to decrease. Studies [69]
were also carried out to investigate the effect of pH and temperature on immobilized bacteria used
for production of acetic acid. The studies showed that there was no significant alteration for the
production of acetic acid on changing the temperature and pH for immobilized bacteria [69].
3.2. Encapsulation of Probiotic Bacteria
Probiotics are live microorganisms which confer health benefits to the host by maintaining or
improving their intestinal microflora [70]. Today there are many probiotic-based health products
available in the market in the form of fermented dairy products as well as dietary supplements.
Probiotic bacteria have to survive during the time from processing to consumption of a food product.
They need to be protected from processing conditions (temperature, oxidation, etc.), storage conditions
(moisture, oxygen, and temperature), high acidic conditions in the stomach and bile salts in the small
intestine. The encapsulation techniques are developed to enhance the viability of these microorganisms
in food products as well as in the gastrointestinal tract [71]. The matrix used for the encapsulation
should have (a) chemical, physical, and biological stability during the production process (b) sufficient
mechanical strength (c) biocompatibility (d) biodegradability (e) higher loading capacity (f) physical
characteristics such as porosity, compression and swelling [72].
Alginate matrices are attractive candidates for the encapsulation of probiotic microorganisms due
to their versatility, biocompatibility and non-toxicity. Probiotic strains namely Staphylococcus succinus
and Enterococcus fecium co-encapsulated with complementary prebiotics on alginate matrix. They
used an oligosaccharide-rich carbohydrate source as such in encapsulation, and was found to
have an improved survival rate of probiotic strains. Results revealed that alginate microspheres
were more densely loaded with probiotic bacteria. Co-encapsulated cells showed approximately
88.75%–98.75% of survivability when exposed to simulated gastric environment [73]. Lactobacillus casei
and Bifidobacterium bifidum were encapsulated using calcium alginate-gelatinized starch with chitosan
coating. The results showed that the survival of probiotic bacteria within encapsulated matrix
increased significantly in simulated gastro-intestinal condition. Gelatinized starch with chitosan
coating reduced the porosity and decreased the cell leakage of encapsulated probiotics. The results
proved that the reduction of pore size and distribution of gastric juice in double coated sodium alginate
membrane lead to limitation of interaction between cells with the gastric juice [74]. Moreover, cellulose
acetate phthalate (a cellulose derivative polymer) is physiologically inert and can be used for the
encapsulation of probiotic bacteria for the delivery in the intestinal tract. Bifidobacterium pseudolongum
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was encapsulated in cellulose acetate phthalate using phase separation-coacervation technique.
Bifidobacterium pseudolongum is used for the replacement therapy for several bacterial-induced
gastrointestinal disorders. Results revealed that the microencapsulated B. pseudolongum survived
in the simulated gastric environment in larger numbers than non-encapsulated B. pseudolongum.
Therefore, microencapsulation of B. pseudolongum in cellulose acetate phthalate seem to offer an
effective way of delivering large numbers of viable bacterial cells to the gastrointestinal tract [75].
3.3. Antimicrobial Food Packaging
Traditionally antimicrobial agents are mixed during the food formulating stage to prevent the
growth of microorganisms and to extend the shelf life of the food. Reactions and the interactions of
antimicrobial agents with the food system cause neutralization and decrease or cease the protective
ability. Also, the antimicrobial agent cannot penetrate to the surface of the food where the food
spoilages are more intensive. To overcome these limitations, antimicrobial packaging materials
were developed with controlled releasing rates [76]. Development of antimicrobial packaging
material by using biopolymers is a great attempt towards attaining sustainability in food packaging
applications [77].
There are several approaches of incorporation of antimicrobial agent to the food packing material.
One is mixing of the antimicrobial agent in the extruder when the film is produced. This is a poor cost
effective method. It is due to the fact that antimicrobial agent which is not exposed to the surface of
the film will not involve with antimicrobial activity. To overcome this drawback, antimicrobial agent is
introduced to the food contacting layer of multilayer packaging material [15]. Figure 3 illustrates the
releasing of antimicrobial agent from food contacting layer of multilayer packaging material.Polymers 2017, 9, 160  11 of 15 
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Cellulose-based materials are widely used to produce antimicrobial food packaging materials
due to their edibility, biocompatibility, barrier properties, non-toxicity and low cost. Gemili et al. [78]
developed cellulose acetate (CA) films with different morphological features to study the release rates of
low molecular weight natural antioxidants (L-ascorbic acid and L-tyrosine). It was found that porosity
and pore size of the film was decreased with increasing the cellulose acetate concentration. This has
caused a reduction of diffusion rates of both antioxidants through the film. Highest antioxidant activity
was observed with highly porous L-tyrosine containing films. When decreasing the porosity, releasing
of L-ascorbic acid into solution increased due to the trapping of L-tyrosine in dense films. Gemili,
Yemeniciog˘lu and Altınkaya [76] developed a cellulose acetate based antimicrobial food packaging
material for controlled release of lysozyme. The highest soluble lysozyme activity, antimicrobial activity
and release rate were obtained in the film prepared from 5% cellulose acetate solution including 1.5%
lysozyme. It was observed that with increasing cellulose acetate concentration of the casting solution
decreased the porosity of the films, as a result, reduced the release rate, maximum released lysozyme
activities and the antimicrobial activities of the films. Potassium sorbate loaded cellulose acetate
food packaging material was developed using supercritical phase inversion process. It was observed
that the mean pore size of membrane increased with increasing the temperature and decreasing the
pressure of the supercritical phase inversion process. In addition, the mean pore size decreased with
increasing the cellulose acetate content of the film. The release pattern of potassium sorbate was
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consistent with the decrease of mean pore size of the membrane. Therefore, the release rates can
be controlled by varying supercritical process condition and the cellulose acetate concentration of
the film [79,80]. Chen et al. [81] prepared antimicrobial methylcellulose films containing chitosan
and sodium benzoate or potassium sorbate to study the antimicrobial activity on Penicillium notatum
and Rhodotomla nibra. The methylcellulose films with 2% antimicrobial agent showed a clear zone at
the film/medium interface and the area around the disc. However, chitosan film containing 2% of
antimicrobial agent was not showed a clear inhibitory zone around the film disc. The film composed
of both methylcellulose and chitosan containing 4% antimicrobial agent was able to release the
antimicrobial agents and showed clear inhibitory zone during incubation. Nisin grafted carboxylated
cellulose nanofiber films were investigated for long term antimicrobial active food packaging. It was
found that film showed an excellent antimicrobial activity on different Gram +ve bacteria with 3.5 log
reduction of initial population [82].
4. Conclusions
Biopolymers offer developers the tremendous flexibility to design porous matrices to broaden
its applications in different areas day by day. Different applications require a unique set of pore
characteristics in the biopolymer matrix. In tissue engineering applications, appropriate scaffold pore
sizes are required to facilitate seeding cells in the middle of the scaffold and for feeding the inner parts
of the scaffolds by diffusion of nutrients to cells within the template and to the extra-cellular medium.
Porous biopolymer matrices are popular candidates for drug delivery applications due to controllable
pore sizes, high surface area, with narrow distribution and favorable surface properties. Pore size of
the matrix plays a major role in drug diffusion kinetics. Chitosan, collagen, hyaluronic acid, alginate
and elastin are attractive biopolymers as wound dressing materials due to the fungicidal properties,
ability of providing extra cellular matrix, load-bearing and stretchable properties and absorbing large
exudate volumes in wounds. In brewing and wine making industry, immobilization of microorganisms
to biomaterials inhibits the toxic influence of produced ethanol on microorganisms and improves the
process conditions as well as the properties of the product. Probiotic microorganisms encapsulated
in biopolymer matrices can prevent contact with the extreme conditions in the gastrointestinal tract
and hence providing more health benefits of probiotic products to the host. Antimicrobial packaging
materials are developed with controlled releasing rates to overcome the food spoilages occur in surface
of the foods. Preparation of biopolymer films containing antimicrobial agents is also a great attempt
towards attaining sustainability in food packaging applications.
It can be seen that freeze-drying and supercritical fluid processing are widely used for the
fabrication of porous scaffold for tissue engineering and wound healing matrices. This is due to the fact
that these methods do not involve any organic solvent which may be harmful to interacting cells and
this has ensured that no harmful residual solvents retained in the scaffolds after processing. While, the
simple and versatile methods such as thermally induced phase separation and freeze drying process are
widely used for fabrication of porous biomaterial for drug delivery and microbiological applications.
In summary, the advantages of biomaterials such as biodegradability, biocompatibility, easy
availability, etc., have outweighed the limitations of synthetic materials for applications in fields such
as biomedical and microbiology. It’s not compulsory for life changing developments to be high-tech
devices with out-of-sight expectations. Sometimes the simplest contrivance can lead to a greater
progress than expensive and advanced technologies. This is true for bio-based porous materials, too.
The emerging properties of these materials lead to a pronounced increase in the range of use and the
efficacy of biomaterials.
Acknowledgments: The authors would like to acknowledge the financial support from the Ministry of Education
Malaysia: High Impact Research MoE Grant UM.C/625/1/HIR/MoE/52, FP030-2013A and FP053-2015A;
University Malaya research grant: RU022A-2014, RP011A-13AET, PG160-2016A and RU018I-2016 for the success
of this project.
Polymers 2017, 9, 160 13 of 16
Author Contributions: T. M. S. Udenni Gunathilake and Yern Chee Ching wrote the paper;
T. M. S. Udenni Gunathilake, Yern Chee Ching, Kuan Yong Ching, Luqman Chuah Abdullah and Cheng
Hock Chuah initiated and contributed to the scope of the manuscript; Yern Chee Ching, Kuan Yong Ching, and
Luqman Chuah Abdullah critically reviewed the manuscript.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Rubentheren, V.; Thomas, A.W.; Ching, Y.C.; Praveena, N.; Erfan, S.; Christopher, F. Effects of heat treatment
on chitosan nanocomposite film reinforced with nanocrystalline cellulose and tannic acid. Carbohydr. Polym.
2016, 140, 202. [CrossRef] [PubMed]
2. Kucin´ska-Lipka, J.; Guban´ska, I.; Janik, H. Polyurethanes modified with natural polymers for medical
application Part II: Polyurethane/gelatin, polyurethane/starch, polyurethane/cellulose. Polimery 2014, 3,
197. [CrossRef]
3. Pan, P.; Wu, S.; Hu, X.; Liu, G.; Li, B. Effect of material composition and environmental condition on thermal
characteristics of conductive asphalt concrete. Materials 2017, 10, 218. [CrossRef]
4. Isikgor, F.H.; Becer, C.R. Lignocellulosic biomass: A sustainable platform for the production of bio-based
chemicals and polymers. Polym. Chem. 2015, 6, 4497–4559. [CrossRef]
5. Vroman, I.; Tighzert, L. Biodegradable polymers. Materials 2009, 2, 307–344. [CrossRef]
6. Gunathilake, T.M.S.U.; Ching, Y.C.; Chuah, C.H. Synthesis and characterization of nanocellulose reinforced
semi-interpenetrating polymer network of chitosan hydrogel. Cellulose 2017, 24, 2215–2228.
7. Mohd, A.C.M.; Ching, Y.C.; Luqman, C.A.; Poh, S.C.; Chuah, C.H. Review of bionanocomposite coating
films and their applications. Polymers 2016, 8, 246.
8. Ching, Y.C.; Ershad, A.; Luqman, C.A.; Choo, K.W.; Yong, C.K.; Sabariah, J.J.; Chuah, C.H.; Liou, N.S.
Rheological properties of cellulose nanocrystal-embedded polymer composites: A review. Cellulose 2016, 23,
1011–1030. [CrossRef]
9. Williams, D.F. There is no such thing as a biocompatible material. Biomaterials 2014, 35, 10009–10014.
[CrossRef] [PubMed]
10. Williams, D.F. On the nature of biomaterials. Biomaterials 2009, 30, 5897–5909. [CrossRef] [PubMed]
11. Rubentheren, V.; Ward, T.A.; Chee, C.Y.; Tang, C.K. Processing and analysis of chitosan nanocomposites
reinforced with chitin whiskers and tannic acid as a crosslinker. Carbohydr. Polym. 2015, 115, 379–387.
[CrossRef] [PubMed]
12. Choo, K.W.; Ching, Y.C.; Chuah, C.H.; Sabariah, J.; Liou, N.S. Preparation and characterization of polyvinyl
alcohol-chitosan composite films reinforced with cellulose nanofiber. Materials 2016, 9, 644. [CrossRef]
13. Ching, Y.C.; Rahman, A.; Ching, K.Y.; Sukiman, N.L.; Cheng, H.C. Preparation and characterization of
polyvinyl alcohol-based composite reinforced with nanocellulose and nanosilica. Bio. Resources 2015, 10,
3364–3377. [CrossRef]
14. Rubentheren, V.; Ward, T.A.; Chee, C.Y.; Nair, P. Physical and chemical reinforcement of chitosan film using
nanocrystalline cellulose and tannic acid. Cellulose 2015, 22, 2529–2541. [CrossRef]
15. Mok, C.F.; Ching, Y.C.; Muhamad, F.; Abu Osman, N.A.; Ramesh, S. Poly(vinyl alcohol)-α-chitin composites
reinforced by oil palm empty fruit bunch fiber-derived nanocellulose. Int. J. Polym. Anal. Charact. 2017, 128,
339–345. [CrossRef]
16. Annabi, N.; Nichol, J.W.; Zhong, X.; Ji, C.; Koshy, S.; Khademhosseini, A.; Dehghani, F. Controlling the
porosity and microarchitecture of hydrogels for tissue engineering. Tissue Eng. B Rev. 2010, 16, 371–383.
[CrossRef] [PubMed]
17. Yadav, P.; Yadav, H.; Shah, V.G.; Shah, G.; Dhaka, G. Biomedical biopolymers, their origin and evolution in
biomedical sciences: A systematic review. J. Clin. Diagn. Res. JCDR 2015, 9, ZE21. [CrossRef] [PubMed]
18. Westman, J.O.; Ylitervo, P.; Franzén, C.J.; Taherzadeh, M.J. Effects of encapsulation of microorganisms
on product formation during microbial fermentations. Appl. Microbiol. Biotechnol. 2012, 96, 1441–1454.
[CrossRef] [PubMed]
19. Abdelaal, O.A.; Darwish, S.M. Fabrication of tissue engineering scaffolds using rapid prototyping techniques.
World Acad. Sci. Eng. Technol. Int. J. Mech. Aerosp. Ind. Mechatron. Manuf. Eng. 2011, 5, 2317–2325.
20. Ji, C.; Annabi, N.; Khademhosseini, A.; Dehghani, F. Fabrication of porous chitosan scaffolds for soft tissue
engineering using dense gas CO2. Acta Biomater. 2011, 7, 1653–1664. [CrossRef] [PubMed]
Polymers 2017, 9, 160 14 of 16
21. Ahuja, G.; Pathak, K. Porous carriers for controlled/modulated drug delivery. Indian J. Pharm. Sci. 2009, 71,
599. [CrossRef] [PubMed]
22. Cam, C.; Zhu, S.; Truong, N.F.; Scumpia, P.O.; Segura, T. Systematic evaluation of natural scaffolds in
cutaneous wound healing. J. Mater. Chem. B 2015, 3, 7986–7992. [CrossRef] [PubMed]
23. Yeung, T.W.; Üçok, E.F.; Tiani, K.A.; McClements, D.J.; Sela, D.A. Microencapsulation in alginate and
chitosan microgels to enhance viability of bifidobacterium longum for oral delivery. Front. Microbiol. 2016, 7.
[CrossRef] [PubMed]
24. O’brien, F.J. Biomaterials & scaffolds for tissue engineering. Mater. Today 2011, 14, 88–95.
25. Baillargeon, A.L.; Mequanint, K. Biodegradable polyphosphazene biomaterials for tissue engineering and
delivery of therapeutics. BioMed Res. Int. 2014, 2014, 761373. [CrossRef] [PubMed]
26. El-Sherbiny, I.M.; Yacoub, M.H. Hydrogel scaffolds for tissue engineering: Progress and challenges.
Glob. Cardiol. Sci. Pract. 2013, 38, 364–371. [CrossRef] [PubMed]
27. O’Brien, F.J.; Harley, B.; Yannas, I.V.; Gibson, L.J. The effect of pore size on cell adhesion in collagen-gag
scaffolds. Biomaterials 2005, 26, 433–441. [CrossRef] [PubMed]
28. Yannas, I.; Lee, E.; Orgill, D.; Skrabut, E.; Murphy, G. Synthesis and characterization of a model extracellular
matrix that induces partial regeneration of adult mammalian skin. Proc. Natl. Acad. Sci. USA 1989, 86,
933–937. [CrossRef] [PubMed]
29. Zeltinger, J.; Sherwood, J.K.; Graham, D.A.; Müeller, R.; Griffith, L.G. Effect of pore size and void fraction on
cellular adhesion, proliferation, and matrix deposition. Tissue Eng. 2001, 7, 557–572. [CrossRef] [PubMed]
30. Salem, A.K.; Stevens, R.; Pearson, R.; Davies, M.; Tendler, S.; Roberts, C.; Williams, P.; Shakesheff, K.
Interactions of 3T3 fibroblasts and endothelial cells with defined pore features. J. Biomed. Mater. Res. 2002,
61, 212–217. [CrossRef] [PubMed]
31. Murphy, C.M.; O’Brien, F.J. Understanding the effect of mean pore size on cell activity in
collagen-glycosaminoglycan scaffolds. Cell Adhes. Migr. 2010, 4, 377–381. [CrossRef]
32. Ma, H.; Hu, J.; Ma, P.X. Polymer scaffolds for small-diameter vascular tissue engineering. Adv. Funct. Mater.
2010, 20, 2833–2841. [CrossRef] [PubMed]
33. Pavia, F.C.; La Carrubba, V.; Piccarolo, S.; Brucato, V. Polymeric scaffolds prepared via thermally induced
phase separation: Tuning of structure and morphology. J. Biomed. Mater. Res. A 2008, 86, 459–466. [CrossRef]
[PubMed]
34. Martel-Estrada, S.A.; Martínez-Pérez, C.A.; Chacón-Nava, J.G.; García-Casillas, P.E.; Olivas-Armendariz, I.
Synthesis and thermo-physical properties of chitosan/poly (DL-lactide-co-glycolide) composites prepared by
thermally induced phase separation. Carbohydr. Polym. 2010, 81, 775–783. [CrossRef]
35. Li, J.; Pan, J.; Zhang, L.; Guo, X.; Yu, Y. Culture of primary rat hepatocytes within porous chitosan scaffolds.
J. Biomed. Mater. Res. A 2003, 67, 938–943. [CrossRef] [PubMed]
36. Kazemzadeh Narbat, M.; Orang, F.; Solati Hashtjin, M.; Goudarzi, A. Fabrication of porous
hydroxyapatite-gelatin composite scaffolds for bone tissue engineering. Iran. Biomed. J. 2006, 10, 215–223.
37. Hilmi, A.; Halim, A.S.; Hassan, A.; Lim, C.K.; Noorsal, K.; Zainol, I. In vitro characterization of a chitosan
skin regenerating template as a scaffold for cells cultivation. Springerplus 2013, 2, 79. [CrossRef] [PubMed]
38. Mou, Z.-L.; Zhao, L.-J.; Zhang, Q.-A.; Zhang, J.; Zhang, Z.-Q. Preparation of porous PLGA/HA/collagen
scaffolds with supercritical CO2 and application in osteoblast cell culture. J. Supercrit. Fluids 2011, 58, 398–406.
[CrossRef]
39. Teng, X.; Ren, J.; Gu, S. Preparation and characterization of porous PDLLA/HA composite foams by
supercritical carbon dioxide technology. J. Biomed. Mater. Res. B Appl. Biomater. 2007, 81, 185–193. [CrossRef]
[PubMed]
40. Bozsak, F.; Gonzalez-Rodriguez, D.; Sternberger, Z.; Belitz, P.; Bewley, T.; Chomaz, J.-M.; Barakat, A.I.
Optimization of drug delivery by drug-eluting stents. PLoS ONE 2015, 10, e0130182. [CrossRef] [PubMed]
41. Bhattarai, N.; Gunn, J.; Zhang, M. Chitosan-based hydrogels for controlled, localized drug delivery. Adv. Drug
Deliv. Rev. 2010, 62, 83–99. [CrossRef] [PubMed]
42. Lin, C.-C.; Metters, A.T. Hydrogels in controlled release formulations: Network design and mathematical
modeling. Adv. Drug Deliv. Rev. 2006, 58, 1379–1408. [CrossRef] [PubMed]
43. Phaechamud, T.; Charoenteeraboon, J. Antibacterial activity and drug release of chitosan sponge containing
doxycycline hyclate. AAPS PharmSciTech 2008, 9, 829–835. [CrossRef] [PubMed]
Polymers 2017, 9, 160 15 of 16
44. Mirzaei, B.E.; Ramazani, S.A.A.; Shafiee, M.; Danaei, M. Studies on glutaraldehyde crosslinked chitosan
hydrogel properties for drug delivery systems. Int. J. Polym. Mater. Polym. Biomater. 2013, 62, 605–611.
[CrossRef]
45. Dorj, B.; Won, J.-E.; Purevdorj, O.; Patel, K.D.; Kim, J.-H.; Lee, E.-J.; Kim, H.-W. A novel therapeutic design
of microporous-structured biopolymer scaffolds for drug loading and delivery. Acta Biomater. 2014, 10,
1238–1250. [CrossRef] [PubMed]
46. Pichatborvonkul, P.; Kaewsrichan, J.; Kaewsichan, L. Development of hydroxyapatite-chitosan beads as a
sustained drug delivery system to bone. Tissue Eng. Regen. Med. Soc. Malays. 2012, 1, 66–73.
47. Barbucci, R.; Leone, G.; Vecchiullo, A. Novel carboxymethylcellulose-based microporous hydrogels suitable
for drug delivery. Biomater. Sci. Polym. Ed. 2004, 15, 607–619. [CrossRef]
48. Chavda, H.; Modhia, I.; Mehta, A.; Patel, R.; Patel, C. Development of bioadhesive chitosan superporous
hydrogel composite particles based intestinal drug delivery system. BioMed Res. Int. 2013, 2013, 563651.
[CrossRef] [PubMed]
49. Gupta, N.V.; Shivakumar, H. Preparation and characterization of superporous hydrogels as gastroretentive
drug delivery system for rosiglitazone maleate. Daru 2010, 18, 200–210.
50. Chavda, H.; Patel, C. Preparation and in vitro evaluation of a stomach specific drug delivery system based
on superporous hydrogel composite. Indian J. Pharm. Sci. 2011, 73, 30. [CrossRef] [PubMed]
51. Udeni Gunathilake, T.M.S.; Ching, Y.C.; Chuah, C.H. Enhancement of curcumin bioavailability using
nanocellulose reinforced chitosan hydrogel. Polymers 2017, 9, 64. [CrossRef]
52. Ghosh, S.; Jassal, M. Use of polysaccharide fibres for modern wound dressings. Indian J. Fibre Text. Res. 2002,
27, 434–452.
53. Piraino, F.; Selimovic´, Š. A current view of functional biomaterials for wound care, molecular and cellular
therapies. BioMed Res. Int. 2015, 2015, 403801. [CrossRef] [PubMed]
54. Lai, C.; Chen, Y.; Zhang, S. Study on chitosan-lactate sponges with oriented pores as potential wound
dressing. Mater. Sci. Appl. 2013, 4, 458–470. [CrossRef]
55. Griffin, D.R.; Weaver, W.M.; Scumpia, P.O.; Di Carlo, D.; Segura, T. Accelerated wound healing by injectable
microporous gel scaffolds assembled from annealed building blocks. Nat. Mater. 2015, 14, 737–744. [CrossRef]
[PubMed]
56. Straccia, M.C.; d’Ayala, G.G.; Romano, I.; Oliva, A.; Laurienzo, P. Alginate hydrogels coated with chitosan
for wound dressing. Mar. Drugs 2015, 13, 2890–2908. [CrossRef] [PubMed]
57. Moreno-Arotzena, O.; Meier, J.G.; Del Amo, C.; Garcia-Aznar, J.M. Characterization of fibrin and collagen
gels for engineering wound healing models. Materials 2015, 8, 1636–1651. [CrossRef] [PubMed]
58. Kim, J.O.; Park, J.K.; Kim, J.H.; Jin, S.G.; Yong, C.S.; Li, D.X.; Choi, J.Y.; Woo, J.S.; Yoo, B.K.; Lyoo, W.S.
Development of polyvinyl alcohol-sodium alginate gel-matrix-based wound dressing system containing
nitrofurazone. Int. J. Pharm. 2008, 359, 79–86. [CrossRef] [PubMed]
59. El Salmawi, K.M. Gamma radiation-induced crosslinked PVA/chitosan blends for wound dressing.
J. Macromol. Sci. A 2007, 44, 541–545. [CrossRef]
60. Stolarzewicz, I.; Białecka-Florjan´czyk, E.; Majewska, E.; Krzyczkowska, J. Immobilization of yeast on
polymeric supports. Chem. Biochem. Eng. Q. 2011, 25, 135–144.
61. Verbelen, P.J.; De Schutter, D.P.; Delvaux, F.; Verstrepen, K.J.; Delvaux, F.R. Immobilized yeast cell systems
for continuous fermentation applications. Biotechnol. Lett. 2006, 28, 1515–1525. [CrossRef] [PubMed]
62. Nedovic, V.A.; Obradovic, B.; Leskosek-Cukalovic, I.; Vunjak-Novakovic, G. Immobilized yeast bioreactor
systems for brewing—Recent achievements. In Engineering and Manufacturing for Biotechnology; Springer:
Berlin, Germany, 2001; pp. 277–292.
63. Willaert, R.; Nedovic, V.A. Primary beer fermentation by immobilised yeast—A review on flavour formation
and control strategies. J. Chem. Technol. Biotechnol. 2006, 81, 1353–1367. [CrossRef]
64. Jovanovic´-Malinovska, R.; Cvetkovska, M.; Kuzmanova, S.; Tsvetanov, C.; Winkelhausen, E. Immobilization
of saccharomyces cerevisiae in novel hydrogels based on hybrid networks of poly(ethylene oxide), alginate
and chitosan for ethanol production. Maced. J. Chem. Chem. Eng. 2010, 29, 169–179.
65. Wang, C. Immobilization of Gluconobacter oxydans by entrapment in porous chitosan sponge. J. Bioprocess.
Biotech. 2013, 3, 132. [CrossRef]
66. Saeki, A. Studies on acetic acid fermentation, 2: Vinegar production using immobilized Acetobacter aceti cells
entrapped in calcium alginate gel beads. J. Jpn. Soc. Food Sci. Technol. 1990, 37, 191–198. [CrossRef]
Polymers 2017, 9, 160 16 of 16
67. Fumi, M.D.; Silva, A.; Battistotti, G.; Colagrande, O. Living immobilized acetobacter in CA-alginate in
vinegar production: Perliminary study on optimum conditions for immobilization. Biotechnol. Lett. 1992, 14,
605–608. [CrossRef]
68. Sun, Y.; Furusaki, S. Continuous production of acetic acid using immobilized Acetobacter aceti in a three-phase
fluidized bed bioreactor. J. Ferment. Bioeng. 1990, 69, 102–110. [CrossRef]
69. Krisch, J.; Szajáni, B. Effects of immobilization on biomass production and acetic acid fermentation of
Acetobacter aceti as a function of temperature and ph. Biotechnol. Lett. 1996, 18, 393–396. [CrossRef]
70. Saarela, M.; Mogensen, G.; Fondén, R.; Mättö, J.; Mattila-Sandholm, T. Probiotic bacteria: Safety, functional
and technological properties. J. Biotechnol. 2000, 84, 197–215. [CrossRef]
71. Kailasapathy, K. Microencapsulation of probiotic bacteria: Technology and potential applications. Curr. Issues
Intest. Microbiol. 2002, 3, 39–48. [PubMed]
72. Mitropoulou, G.; Nedovic, V.; Goyal, A.; Kourkoutas, Y. Immobilization technologies in probiotic food
production. J. Nutr. Metab. 2013, 2013, 716861. [CrossRef] [PubMed]
73. Sathyabama, S.; Vijayabharathi, R. Co-encapsulation of probiotics with prebiotics on alginate matrix and its
effect on viability in simulated gastric environment. LWT Food Sci. Technol. 2014, 57, 419–425. [CrossRef]
74. Zanjani, M.A.K.; Tarzi, B.G.; Sharifan, A.; Mohammadi, N. Microencapsulation of probiotics by calcium
alginate-gelatinized starch with chitosan coating and evaluation of survival in simulated human
gastro-intestinal condition. Iran. J. Pharm. Res. 2014, 13, 843.
75. Rao, A.; Shiwnarain, N.; Maharaj, I. Survival of microencapsulated Bifidobacterium pseudolongum in simulated
gastric and intestinal juices. Can. Inst. Food Sci. Technol. J. 1989, 22, 345–349. [CrossRef]
76. Gemili, S.; Yemeniciog˘lu, A.; Altınkaya, S.A. Development of cellulose acetate based antimicrobial food
packaging materials for controlled release of lysozyme. J. Food Eng. 2009, 90, 453–462. [CrossRef]
77. Mangalassary, S. Antimicrobial food packaging to enhance food safety: Current developments and future
challenges. J. Food Process. Technol. 2012, 3, 2157–2164. [CrossRef]
78. Gemili, S.; Yemeniciog˘lu, A.; Altınkaya, S.A. Development of antioxidant food packaging materials with
controlled release properties. J. Food Eng. 2010, 96, 325–332. [CrossRef]
79. Baldino, L.; Cardea, S.; Reverchon, E. Production of antimicrobial membranes loaded with potassium sorbate
using a supercritical phase separation process. Innov. Food Sci. Emerg. Technol. 2016, 34, 77–85. [CrossRef]
80. Sampath, U.G.; Ching, Y.C.; Chuah, C.H.; Sabariah, J.J.; Lin, P.-C. Fabrication of porous materials from
natural/synthetic biopolymers and their composites. Materials 2016, 9, 991. [CrossRef]
81. Chen, M.C.; Yeh, G.H.C.; Chiang, B.H. Antimicrobial and physicochemical properties of methylcellulose and
chitosan films containing a preservative. J. Food Process. Preserv. 1996, 20, 379–390. [CrossRef]
82. Saini, S.; Sillard, C.; Belgacem, M.N.; Bras, J. Nisin anchored cellulose nanofibers for long term antimicrobial
active food packaging. RSC Adv. 2016, 6, 12422–12430. [CrossRef]
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
